| Entry |
|
|---|
| Name |
Glymidine sodium (JAN/USAN/INN) |
|---|
| Formula |
C13H14N3O4S. Na
|
|---|
| Exact mass |
331.0603
|
|---|
| Mol weight |
331.32
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antidiabetic agent
DG01508 Sulfonylurea receptor agonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Antidiabetic, Hypoglycemic, Sulfonylurea receptor agonist |
|---|
| Comment |
Sulfonamide derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07018 | Sulfonamide derivatives - hypoglycemic agents |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BC Sulfonamides (heterocyclic)
A10BC01 Glymidine
D01356 Glymidine sodium (JAN/USAN/INN)
Drug groups [BR:br08330]
Antidiabetic agent
DG01508 Sulfonylurea receptor agonist
D01356 Glymidine sodium
Target-based classification of drugs [BR:br08310]
Transporters
ABC transporters
ABCC subfamily
ABCC8(SUR1)/KCNJ11(KIR6.2)
D01356 Glymidine sodium (JAN/USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 22
1 C8x C 14.6534 -17.5221
2 C8x C 14.6534 -18.9216
3 C8x C 15.8684 -19.6214
4 C8x C 17.0762 -18.9216
5 C8y C 17.0762 -17.5221
6 C8x C 15.8684 -16.8224
7 S4a S 18.2887 -16.8234
8 N1b N 19.5003 -17.5240 #-
9 O3c O 19.2760 -15.8257
10 O3c O 17.2899 -15.8257
11 C8y C 20.7129 -16.8251
12 N5x N 21.9207 -17.5260
13 C8x C 23.1332 -16.8273
14 C8y C 23.1343 -15.4278
15 C8x C 21.9227 -14.7270
16 N5x N 20.7103 -15.4259
17 O2a O 24.3468 -14.7289
18 C1b C 25.5582 -15.4295
19 C1b C 26.7708 -14.7307
20 O2a O 27.9823 -15.4313
21 C1a C 29.1949 -14.7324
22 Z Na 24.9448 -19.0984 #+
BOND 22
1 3 4 2
2 8 11 1
3 4 5 1
4 5 6 2
5 6 1 1
6 5 7 1
7 11 12 2
8 12 13 1
9 13 14 2
10 14 15 1
11 15 16 2
12 16 11 1
13 14 17 1
14 7 8 1
15 17 18 1
16 1 2 2
17 18 19 1
18 7 9 2
19 19 20 1
20 2 3 1
21 20 21 1
22 7 10 2
|
|---|
